- Nachrichtendetail
-
28.06.2024 16:33:21 - dpa-AFX: *J&J : RYBREVANT COMBINATION APPROVED IN EUROPE FOR FIRST-LINE TREATMENT OF NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 158,970 | 29.07.24 21:53:55 | -1,670 | -1,04% | 158,960 | 158,980 | 159,750 | 160,640 |
